CellSeed (TSE:7776) Cyclically Adjusted PS Ratio: (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7776 CellSeed Inc TSE:7776
55 GF Score
Price 円206.00
GF Value 円160.95
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is CellSeed Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CellSeed  (TSE:7776) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


CellSeed Cyclically Adjusted PS Ratio Related Terms


CellSeed Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for CellSeed's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSeed Cyclically Adjusted PS Ratio Chart

CellSeed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.47 7.73 12.73 0.00 0.00

CellSeed Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.51 22.14 0.00 0.00 0.00

TSE:7776 vs VRTX, REGN, RVMD: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, CellSeed's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSeed Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSeed's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CellSeed's Cyclically Adjusted PS Ratio falls into.


TSE:7776
55GF Score
CellSeed Inc TSE:7776
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellSeed Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

CellSeed's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 is calculated as:

For example, CellSeed's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0/113.0000*113.0000
=0.000

Current CPI (Dec. 2025) = 113.0000.

CellSeed Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 17.314 98.100 19.944
201603 0.854 97.900 0.986
201606 2.223 98.100 2.561
201609 0.940 98.000 1.084
201612 6.937 98.400 7.966
201703 1.387 98.100 1.598
201706 1.279 98.500 1.467
201709 1.460 98.800 1.670
201712 3.743 99.400 4.255
201803 9.747 99.200 11.103
201806 20.698 99.200 23.577
201809 17.113 99.900 19.357
201812 42.115 99.700 47.733
201903 10.291 99.700 11.664
201906 3.877 99.800 4.390
201909 4.062 100.100 4.585
201912 5.020 100.500 5.644
202003 2.350 100.300 2.648
202006 1.899 99.900 2.148
202009 1.746 99.900 1.975
202012 7.223 99.300 8.220
202103 2.522 99.900 2.853
202106 2.301 99.500 2.613
202109 2.659 100.100 3.002
202112 1.850 100.100 2.088
202203 2.093 101.100 2.339
202206 1.654 101.800 1.836
202209 0.612 103.100 0.671
202212 1.566 104.100 1.700
202303 1.136 104.400 1.230
202306 1.278 105.200 1.373
202309 1.691 106.200 1.799
202312 2.255 106.800 2.386
202403 1.079 107.200 1.137
202406 1.258 108.200 1.314
202412 0.000 110.700 0.000
202503 0.774 111.100 0.787
202506 0.294 111.700 0.297
202509 0.000 112.000 0.000
202512 0.000 113.000 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is CellSeed (TSE:7776) Overvalued in 2026?

Based on GuruFocus' analysis, CellSeed stock appears to be overvalued. The current stock price of 円206.00 is trading 28% above its estimated GF Value™ of 円160.95. GuruFocus considers CellSeed to be Modestly Overvalued.

Key valuation signals for TSE:7776:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: 円160.95 vs. price of 円206.00 (28% above fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the TSE:7776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CellSeed Business Description

Address 2-5-10 Aomi, Telecom Center Building, 15th Floor (East Wing, Koto-ku, Tokyo, JPN, 135-0064
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheets for corneal and esophageal regeneration; regenerated cardiac patches to treat heart diseases; cell sheets for periodontal tissue regeneration; and regenerated cartilage sheets for the treatment of osteoarthritis.
55GF Score

Get the complete analysis for TSE:7776

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円206.00
Price
円160.95
GF Value